Cladribine tablet for those with active multiple sclerosis will reduce hospital visits and free up appointments
Thousands of patients with multiple sclerosis (MS) in England are to become the first in Europe to benefit from a major roll out of an immunotherapy pill.
Current treatments involve regular trips to hospital, drug infusions, frequent injections and extensive monitoring, which add to the burden on patients and healthcare systems.
More Stories
As big tech grows more involved in Gaza, Muslim workers are wrestling with a spiritual crisis
Scientists develop methanol breathalyser that could prevent thousands of poisonings each year
Entrepreneur ‘humiliated’ after London Tech Week turns her and baby away